Autism Spectrum Disorder Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Be between 6 and 30 years old
- Have been diagnosed with autism spectrum disorder (ASD)
- Have scored above the ASD threshold on a standard autism assessment called the ADOS-2 (confirm with trial site)
- Also have an intellectual disability, meaning a low IQ or developmental score below 70
- Live in a home where Chinese is the main language spoken
- Have a parent or legal guardian who agrees to give permission for participation
Who may not be able to join:
- Have a genetic condition such as Down syndrome, Fragile X syndrome, or Rett syndrome, or have a current or past diagnosis of severe ADHD, Tourette syndrome, or conditions like schizophrenia, bipolar disorder, or other psychotic disorders
- Have shown serious self-harming or suicidal behaviour at any point in the past year
- Have a significant vision, hearing, or physical movement problem that would make it hard to take part in the study
- Have a current or past diagnosis of epilepsy
- Have a known serious physical illness, especially one that affects the brain
- Have any metal implants in the body that are not safe for MRI or brain stimulation procedures, such as a pacemaker, a stent, or a cochlear implant
- Have a breathing or circulation condition that could make sedation risky, such as sleep apnea or severe snoring
- Have all legal guardians who are unable to read, meaning no guardian can independently read the consent forms or fill in questionnaires
- Have received certain types of brain stimulation treatments (such as TMS, tCS, or focused ultrasound) in the last 3 months
- Are currently taking part in another clinical trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Hesheng Liu, Ph.D., Changping Laboratory
Phone: 010-80726688
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
ADOS-2 SA CSS score change after treatment
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.